BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND CDKN2C, P42773, 1031, ENSG00000123080, INK4C, p18, p18-INK4C AND Diagnosis
9 results:

  • 1. Using health insurance claims data to assess long-term disease progression in a prostate cancer cohort.
    Khan S; Vohra S; Farnan L; Elmore SNC; Toumbou K; K C M; Fontham ETH; Peters ES; Mohler JL; Bensen JT
    Prostate; 2022 Nov; 82(15):1447-1455. PubMed ID: 35880605
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Progression-free survival in patients with
    Werensteijn-Honingh AM; Wevers AFJ; Peters M; Kroon PS; Intven M; Eppinga WSC; Jürgenliemk-Schulz IM
    Acta Oncol; 2021 Oct; 60(10):1342-1351. PubMed ID: 34323648
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Epigenetic Analysis of Circulating Tumor DNA in Localized and Metastatic prostate cancer: Evaluation of Clinical Biomarker Potential.
    Bjerre MT; Nørgaard M; Larsen OH; Jensen SØ; Strand SH; Østergren P; Fode M; Fredsøe J; Ulhøi BP; Mortensen MM; Jensen JB; Borre M; Sørensen KD
    Cells; 2020 May; 9(6):. PubMed ID: 32486483
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Prevalence and predictors of probable depression in prostate cancer survivors.
    Erim DO; Bensen JT; Mohler JL; Fontham ETH; Song L; Farnan L; Delacroix SE; Peters ES; Erim TN; Chen RC; Gaynes BN
    Cancer; 2019 Oct; 125(19):3418-3427. PubMed ID: 31246284
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Complementary Medicine, Refusal of Conventional cancer Therapy, and Survival Among Patients With Curable cancers.
    Johnson SB; Park HS; Gross CP; Yu JB
    JAMA Oncol; 2018 Oct; 4(10):1375-1381. PubMed ID: 30027204
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Radiation-induced complex anterior urinary fistulation for prostate cancer: a retrospective multicenter study from the Trauma and Urologic Reconstruction Network of Surgeons (TURNS).
    Osterberg EC; Vanni AJ; Gaither TW; Awad MA; Broghammer JA; Pate SC; Wyre H; Myers JB; Elliott SP; Krishna S; Zhao LC; McClung C; Erickson BA; Breyer BN
    World J Urol; 2017 Jul; 35(7):1037-1043. PubMed ID: 27928592
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The prognostic significance of the 2014 International Society of Urological Pathology (ISUP) grading system for prostate cancer.
    Samaratunga H; Delahunt B; Gianduzzo T; Coughlin G; Duffy D; LeFevre I; Johannsen S; Egevad L; Yaxley J
    Pathology; 2015 Oct; 47(6):515-9. PubMed ID: 26325670
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Racial differences in trust and regular source of patient care and the implications for prostate cancer screening use.
    Carpenter WR; Godley PA; Clark JA; Talcott JA; Finnegan T; Mishel M; Bensen J; Rayford W; Su LJ; Fontham ET; Mohler JL
    Cancer; 2009 Nov; 115(21):5048-59. PubMed ID: 19637357
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The CAG trinucleotide repeat length in the androgen receptor does not predict the early onset of prostate cancer.
    Mir K; Edwards J; Paterson PJ; Hehir M; Underwood MA; Bartlett JM
    BJU Int; 2002 Oct; 90(6):573-8. PubMed ID: 12230620
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.